These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Clinical evaluation of renal lithiasis. Van Den Berg CJ Geriatrics; 1979 Jul; 34(7):35-42. PubMed ID: 447082 [TBL] [Abstract][Full Text] [Related]
24. Uptake of proteoglycans and sulfated glycosaminoglycans by cultured skin fibroblasts. Truppe W; Kresse H Eur J Biochem; 1978 Apr; 85(2):351-6. PubMed ID: 648525 [No Abstract] [Full Text] [Related]
25. In vitro system for calcium stone formation: the constant composition model. Nancollas GH; Singh RP Contrib Nephrol; 1987; 58():49-58. PubMed ID: 3691147 [No Abstract] [Full Text] [Related]
27. Urinary excretion of glycosaminoglycans in normal and stone forming subjects. Michelacci YM; Glashan RQ; Schor N Kidney Int; 1989 Dec; 36(6):1022-8. PubMed ID: 2601252 [TBL] [Abstract][Full Text] [Related]
34. Mechanisms of stone formation: role of promoters and inhibitors. Fleisch H Scand J Urol Nephrol Suppl; 1980; 53():53-66. PubMed ID: 7010571 [TBL] [Abstract][Full Text] [Related]
35. [Acid glycosaminoglycans by the skin, urine, plasma and skin fibroblasts in a patient with dominant dystrophic epidermolysis bullosa (Cockayne-Touraine type)]. Oyama K; Tajima S; Nishikawa T; Yamasaki Y; Araki Y; Sakuraoka K Nihon Hifuka Gakkai Zasshi; 1987 Sep; 97(10):1095-100. PubMed ID: 3441023 [No Abstract] [Full Text] [Related]
36. Risk factors in calcium stone disease of the urinary tract. Robertson WG; Peacock M; Heyburn PJ; Marshall DH; Clark PB Br J Urol; 1978 Dec; 50(7):449-54. PubMed ID: 37975 [TBL] [Abstract][Full Text] [Related]
37. Turnover of sulfated glycosaminoglycans in fibroblasts derived from patients with Werner's syndrome. Cowles EA; Brauker JH; Anderson RL Exp Cell Res; 1987 Feb; 168(2):347-57. PubMed ID: 3100317 [TBL] [Abstract][Full Text] [Related]
38. [Allopurinol in the therapy of idiopathic calcic lithiasis]. Caudarella R; Stefani F; Malavolta N; Rizzoli E; Maccaferri M; D'Antuono G G Clin Med; 1983; 64(5-6):198-208. PubMed ID: 6618055 [No Abstract] [Full Text] [Related]
39. Skin fibroblast activity in pretibial myxoedema and the effect of octreotide (Sandostatin) in vitro. Priestley GC; Aldridge RD; Sime PJ; Wilson D Br J Dermatol; 1994 Jul; 131(1):52-6. PubMed ID: 8043422 [TBL] [Abstract][Full Text] [Related]
40. Increased biosynthesis of glycosaminoglycans by scleroderma fibroblasts in culture. Bashey RI; Millan A; Jimenez SA Arthritis Rheum; 1984 Sep; 27(9):1040-5. PubMed ID: 6477654 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]